In high-risk patients, point-of-care capillary HbA1c was superior to venous HbA1c as uptake was double, leading to faster ...

China: A recent cluster randomized controlled trial has demonstrated that point-of-care capillary HbA1c (POC-cHbA1c) testing ...

As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to ...

Adults with type 1 diabetes and recurrent severe hypoglycemia reduced their HbA1c to less than 7% with a full dose of VX-880. No severe adverse events associated with the therapy were reported.